{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T17:34:45Z","timestamp":1767893685936,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-024-03608-x","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T03:17:05Z","timestamp":1733368625000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development and validation of a nomogram for predicting outcomes in ovarian cancer patients with liver metastases"],"prefix":"10.1186","volume":"22","author":[{"given":"Huifu","family":"Xiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ningping","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guohai","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiufen","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5998-6081","authenticated-orcid":false,"given":"Jiaojiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"key":"3608_CR1","doi-asserted-by":"publisher","first-page":"956","DOI":"10.3390\/cancers12040956","volume":"12","author":"K Lhotova","year":"2020","unstructured":"Lhotova K, Stolarova L, Zemankova P, Vocka M, Janatova M, Borecka M, et al. Multigene Panel Germline Testing of 1333 Czech patients with ovarian Cancer. Cancers (Basel). 2020;12:956.","journal-title":"Cancers (Basel)"},{"key":"3608_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"3608_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"3608_CR4","doi-asserted-by":"publisher","first-page":"3976","DOI":"10.7150\/jca.47695","volume":"12","author":"S Liu","year":"2021","unstructured":"Liu S, Wu M, Wang F. Research Progress in prognostic factors and biomarkers of ovarian Cancer. J Cancer. 2021;12:3976\u201396.","journal-title":"J Cancer"},{"key":"3608_CR5","doi-asserted-by":"publisher","first-page":"967421","DOI":"10.3389\/fonc.2022.967421","volume":"12","author":"K Anic","year":"2022","unstructured":"Anic K, Schmidt MW, Schmidt M, Krajnak S, L\u00f6we A, Linz VC, et al. Impact of perioperative red blood cell transfusion, anemia of cancer and global health status on the prognosis of elderly patients with endometrial and ovarian cancer. Front Oncol. 2022;12:967421.","journal-title":"Front Oncol"},{"key":"3608_CR6","doi-asserted-by":"publisher","first-page":"972","DOI":"10.6004\/jnccn.2022.0047","volume":"20","author":"DK Armstrong","year":"2022","unstructured":"Armstrong DK, Alvarez RD, Backes FJ, Bakkum-Gamez JN, Barroilhet L, Behbakht K, et al. NCCN Guidelines\u00ae insights: ovarian Cancer, Version 3.2022. J Natl Compr Canc Netw. 2022;20:972\u201380.","journal-title":"J Natl Compr Canc Netw"},{"key":"3608_CR7","doi-asserted-by":"publisher","first-page":"5370","DOI":"10.1007\/s00330-020-06937-z","volume":"30","author":"R Forstner","year":"2020","unstructured":"Forstner R. Early detection of ovarian cancer. Eur Radiol. 2020;30:5370\u20133.","journal-title":"Eur Radiol"},{"key":"3608_CR8","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.ygyno.2018.06.022","volume":"150","author":"K Deng","year":"2018","unstructured":"Deng K, Yang C, Tan Q, Song W, Lu M, Zhao W, et al. Sites of distant metastases and overall survival in ovarian cancer: a study of 1481 patients. Gynecol Oncol. 2018;150:460\u20135.","journal-title":"Gynecol Oncol"},{"key":"3608_CR9","doi-asserted-by":"publisher","first-page":"7255","DOI":"10.7150\/jca.64255","volume":"12","author":"GM Hou","year":"2021","unstructured":"Hou GM, Jiang C, Du JP, Liu C, Chen XZ, Yuan KF, et al. Nomogram models for Predicting Risk and Prognosis of newly diagnosed ovarian Cancer patients with liver metastases - a large Population-based real-world study. J Cancer. 2021;12:7255\u201365.","journal-title":"J Cancer"},{"key":"3608_CR10","doi-asserted-by":"publisher","first-page":"4861","DOI":"10.7150\/jca.40590","volume":"11","author":"I Hussain","year":"2020","unstructured":"Hussain I, Xu J, Deng K, Noor-Ul-Amin, Wang C, Huang Y, et al. The prevalence and associated factors for liver metastases, Development and Prognosis in newly diagnosed epithelial ovarian Cancer: a large Population-based study from the SEER database. J Cancer. 2020;11:4861\u20139.","journal-title":"J Cancer"},{"key":"3608_CR11","doi-asserted-by":"publisher","first-page":"3621","DOI":"10.1200\/JCO.2006.10.2517","volume":"25","author":"WE Winter 3rd","year":"2007","unstructured":"Winter WE 3rd, Maxwell GL, Tian C, Carlson JW, Ozols RF, Rose PG, et al. Prognostic factors for stage III epithelial ovarian cancer: a gynecologic Oncology Group Study. J Clin Oncol. 2007;25:3621\u20137.","journal-title":"J Clin Oncol"},{"key":"3608_CR12","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13048-023-01177-3","volume":"16","author":"W Huang","year":"2023","unstructured":"Huang W, Bao Y, Luo X, Yao L, Yuan L. Do ethnic Chinese older adults with epithelial ovarian cancer survive a poorer prognosis. J Ovarian Res. 2023;16:110.","journal-title":"J Ovarian Res"},{"key":"3608_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1055\/a-1608-1309","volume":"82","author":"C Bekos","year":"2022","unstructured":"Bekos C, Grimm C, Gensthaler L, Bartl T, Reinthaller A, Schwameis R, et al. The pretreatment Controlling Nutritional Status score in Ovarian Cancer: influence on Prognosis, Surgical Outcome, and postoperative complication rate. Geburtshilfe Frauenheilkd. 2022;82:59\u201367.","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"3608_CR14","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ygyno.2023.11.031","volume":"180","author":"S Chauhan","year":"2024","unstructured":"Chauhan S, Langstraat CL, Fought AJ, McGree ME, Cliby WA, Kumar A. Relationship between frailty and nutrition: refining predictors of mortality after primary cytoreductive surgery for ovarian cancer. Gynecol Oncol. 2024;180:126\u201331.","journal-title":"Gynecol Oncol"},{"key":"3608_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12020-023-03477-6","volume":"83","author":"F Karimi","year":"2024","unstructured":"Karimi F, Dinarvand N, Sabaghan M, Azadbakht O, Ataee S, Kharazinejad E, et al. Diabetes and ovarian cancer: risk factors, molecular mechanisms and impact on prognosis. Endocrine. 2024;83:1\u20139.","journal-title":"Endocrine"},{"key":"3608_CR16","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.3390\/cancers14153655","volume":"14","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Zuo J, Li N, Zheng R, Yuan G, Shen G, et al. Differences in Treatment Modalities and prognosis of Elderly patients with ovarian Cancer: a two-Center Propensity score-matched study. Cancers (Basel). 2022;14:3655.","journal-title":"Cancers (Basel)"},{"key":"3608_CR17","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/s10147-011-0223-5","volume":"16","author":"S Hosono","year":"2011","unstructured":"Hosono S, Kajiyama H, Mizuno K, Sakakibara K, Matsuzawa K, Takeda A, et al. Comparison between serous and non-serous ovarian cancer as a prognostic factor in advanced epithelial ovarian carcinoma after primary debulking surgery. Int J Clin Oncol. 2011;16:524\u201332.","journal-title":"Int J Clin Oncol"},{"key":"3608_CR18","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1093\/annonc\/mdw142","volume":"27","author":"M Moschetta","year":"2016","unstructured":"Moschetta M, George A, Kaye SB, Banerjee S. BRCA somatic mutations and epigenetic BRCA modifications in serous ovarian cancer. Ann Oncol. 2016;27:1449\u201355.","journal-title":"Ann Oncol"},{"key":"3608_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10585-019-10007-0","volume":"37","author":"AB Gardner","year":"2020","unstructured":"Gardner AB, Charo LM, Mann AK, Kapp DS, Eskander RN, Chan JK. Ovarian, uterine, and cervical cancer patients with distant metastases at diagnosis: most common locations and outcomes. Clin Exp Metastasis. 2020;37:107\u201313.","journal-title":"Clin Exp Metastasis"},{"key":"3608_CR20","doi-asserted-by":"crossref","unstructured":"Cheng L, Zhang J. Survival analysis of ovarian cancer patients with distant metastasis after chemotherapy: a SEER-based study. Indian J Cancer. 2023.","DOI":"10.4103\/ijc.IJC_175_20"},{"key":"3608_CR21","doi-asserted-by":"publisher","first-page":"m3773","DOI":"10.1136\/bmj.m3773","volume":"371","author":"L Kuroki","year":"2020","unstructured":"Kuroki L, Guntupalli SR. Treatment of epithelial ovarian cancer. BMJ. 2020;371:m3773.","journal-title":"BMJ"},{"key":"3608_CR22","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/S1470-2045(18)30566-7","volume":"19","author":"I Vergote","year":"2018","unstructured":"Vergote I, Coens C, Nankivell M, Kristensen GB, Parmar M, Ehlen T, et al. Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials. Lancet Oncol. 2018;19:1680\u20137.","journal-title":"Lancet Oncol"},{"key":"3608_CR23","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3322\/caac.21559","volume":"69","author":"S Lheureux","year":"2019","unstructured":"Lheureux S, Braunstein M, Oza AM. Epithelial ovarian cancer: evolution of management in the era of precision medicine. CA Cancer J Clin. 2019;69:280\u2013304.","journal-title":"CA Cancer J Clin"},{"key":"3608_CR24","doi-asserted-by":"crossref","unstructured":"Colombo N, Sessa C, du Bois A, Ledermann J, McCluggage WG, McNeish I et al. ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease\u2020. Ann Oncol. 2019;30:672\u2013705.","DOI":"10.1093\/annonc\/mdz062"},{"key":"3608_CR25","doi-asserted-by":"publisher","first-page":"3730","DOI":"10.3390\/cancers12123730","volume":"12","author":"P Charkhchi","year":"2020","unstructured":"Charkhchi P, Cybulski C, Gronwald J, Wong FO, Narod SA, Akbari MR. CA125 and ovarian Cancer: a Comprehensive Review. Cancers (Basel). 2020;12:3730.","journal-title":"Cancers (Basel)"},{"key":"3608_CR26","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ygyno.2024.04.019","volume":"187","author":"A Rosati","year":"2024","unstructured":"Rosati A, De Rose AM, Gallotta V, Giannarelli D, Ghirardi V, Pavone M, et al. Feasibility and operative outcomes of surgery in the liver area in advanced ovarian cancer. Gynecol Oncol. 2024;187:98\u2013104.","journal-title":"Gynecol Oncol"},{"key":"3608_CR27","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s12957-015-0652-0","volume":"13","author":"N Bacalbasa","year":"2015","unstructured":"Bacalbasa N, Dima S, Brasoveanu V, David L, Balescu I, Purnichescu-Purtan R, et al. Liver resection for ovarian cancer liver metastases as part of cytoreductive surgery is safe and may bring survival benefit. World J Surg Oncol. 2015;13:235.","journal-title":"World J Surg Oncol"},{"key":"3608_CR28","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1080\/02656736.2019.1706767","volume":"37","author":"S Zhuo","year":"2020","unstructured":"Zhuo S, Zhou J, Ruan G, Zeng S, Ma H, Xie C, et al. Percutaneous microwave ablation versus surgical resection for ovarian cancer liver metastasis. Int J Hyperth. 2020;37:28\u201336.","journal-title":"Int J Hyperth"},{"key":"3608_CR29","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1016\/j.ejso.2019.06.023","volume":"45","author":"V Gallotta","year":"2019","unstructured":"Gallotta V, Conte C, D\u2019Indinosante M, Capoluongo E, Minucci A, De Rose AM, et al. Prognostic factors value of germline and somatic brca in patients undergoing surgery for recurrent ovarian cancer with liver metastases. Eur J Surg Oncol. 2019;45:2096\u2013102.","journal-title":"Eur J Surg Oncol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-024-03608-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-024-03608-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-024-03608-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T10:45:08Z","timestamp":1733395508000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-024-03608-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3608"],"URL":"https:\/\/doi.org\/10.1186\/s12957-024-03608-x","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,5]]},"assertion":[{"value":"7 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study only used the patients\u2019 anonymous clinical data, and no patient privacy was involved; therefore, ethical approval was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"327"}}